Target therapy for hepatocellular carcinoma: is sorafenib for everybody? Journal of clinical gastroenterology [J Clin Gastroenterol] Journal article

Title	Target therapy for hepatocellular carcinoma: is sorafenib for everybody?
Author(s)	Daniele B, Di Maio M
Institution	*Department of Oncology, G. Rummo Hospital, Benevento daggerClinical Trials Unit, National Cancer Institute, Napoli, Italy.
Source	J Clin Gastroenterol 2009 May-Jun; 43(5):389-90.
Language	eng
Pub Type(s)	Journal Article
PubMed ID	19564813

Advertise on this site.